Global Radiation Therapy Market With Focus on LINAC: Insights & Forecast 2024-2028, Featuring Profiles of Ion Beam Applications, Siemens Healthineers, Accuray, Elekta, ViewRay and Hitachi - ResearchAndMarkets.com
Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers—Let's Preserve ViewRay Technology
Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
Viewray (VRAY.US) executives sold 89,900 common shares worth approximately $6,293.07
It was reported on July 27 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on July 26, $Viewray (VRAY.US) $ executive Podbelski Adam Andrew sold 89,900 common shares at an average price of 0.07 US dollars per share on July 17, with a value of about 6,293.07 US dollars. For details on the disclosing party's derivatives transactions, please refer to the table. This transaction involves another related party: Shah Sanket. Image source: SEC's official website (partial form of this incident) What is a shareholding change statement? SE
News On ViewRay Inc. (VRAY) Now Under VRAYQ